• Alzheimer's Association Denies Conflict in Aducanumab Support

    7 monthes ago - By Medscape

    The Alzheimer's Association denies accusations that its repeated endorsement of aducanumab, a drug under FDA review for Alzheimer's, has been unduly influenced by financial support from two companies seeking its approval.
    Medscape Medical News
    Read more ...